title: Changes in NMDA receptor contribution to synaptic transmission in the brain in a rat model of glaucoma.
abstract: In the age-related, blinding disease glaucoma, retinal ganglion cells (RGCs) degenerate, possibly affecting glutamatergic retinofugal transmission to the brain. The superior colliculus (SC) is a major central target of retinofugal axons in the rodent, a much used disease model. We investigated the contribution of NMDA-type glutamate receptors to retinocollicular transmission in a rat glaucoma model, using a SC brain slice preparation to determine the sensitivity of synaptic responses to the NMDAR antagonist D-AP5. At 32weeks after induction of experimental glaucoma, but not earlier, there was an increase in NMDAR contribution to SC synaptic responses in slices receiving input from glaucomatous eyes. This suggests that there are changes in NMDAR function after RGC degeneration in experimental glaucoma, which may represent functional SC compensation through plasticity via NMDARs. This has implications for studies carried out using rodent glaucoma models, especially those evaluating potential treatment strategies, as it suggests that functional changes in the central visual system need to be considered in addition to those in the eye. Furthermore, the data underline the need for early therapeutic intervention in order to pre-empt subsequent central functional changes.
authors.affiliation: Department of Visual Neuroscience, UCL Institute of Ophthalmology, London, UK.
authors.forename: A L
authors.initials: AL
authors.lastname: Georgiou
authors.forename: L
authors.initials: L
authors.lastname: Guo
authors.forename: M F
authors.initials: MF
authors.lastname: Cordeiro
authors.forename: T E
authors.initials: TE
authors.lastname: Salt
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D004594:Electrophysiology; D019706:Excitatory Postsynaptic Potentials / Q000502:physiology; D005901:Glaucoma / Q000378:metabolism / Q000503:physiopathology*; D008297:Male; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism*; D012165:Retinal Ganglion Cells / Q000502:physiology*; D013477:Superior Colliculi / Q000378:metabolism / Q000503:physiopathology*; D013569:Synapses / Q000378:metabolism; D009435:Synaptic Transmission / Q000502:physiology*; D014795:Visual Pathways / Q000378:metabolism / Q000503:physiopathology*
chemical_list: D016194:Receptors, N-Methyl-D-Aspartate
references.citation: Neuroscience. 2001;104(2):441-54
references.pmid: 11377846
references.citation: Annu Rev Cell Dev Biol. 2008;24:183-209
references.pmid: 18616423
references.citation: Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13352-6
references.pmid: 15340151
references.citation: Neuroscience. 1990;34(2):341-57
references.pmid: 2159128
references.citation: J Neurophysiol. 2003 Apr;89(4):2035-45
references.pmid: 12686577
references.citation: Trends Neurosci. 2007 Jun;30(6):284-91
references.pmid: 17418904
references.citation: J Neurosci. 1997 Aug 15;17(16):6264-76
references.pmid: 9236237
references.citation: Neuropharmacology. 2002 Aug;43(2):231-4
references.pmid: 12213277
references.citation: Brain Res. 1991 Feb 1;540(1-2):255-65
references.pmid: 1647245
references.citation: Neuropharmacology. 1998 Sep;37(9):1111-22
references.pmid: 9833641
references.citation: Neurosci Lett. 1993 Jan 12;149(2):198-200
references.pmid: 8386349
references.citation: Neuropharmacology. 2005;49 Suppl 1:26-34
references.pmid: 16023683
references.citation: Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10593-7
references.pmid: 1359542
references.citation: J Physiol. 2002 Jun 15;541(Pt 3):895-903
references.pmid: 12068048
references.citation: J Neurochem. 1998 Mar;70(3):899-907
references.pmid: 9489708
references.citation: Neuroreport. 2009 Jan 28;20(2):139-44
references.pmid: 19057418
references.citation: J Physiol. 1997 Nov 1;504 ( Pt 3):629-39
references.pmid: 9401970
references.citation: Invest Ophthalmol Vis Sci. 2007 Feb;48(2):733-44
references.pmid: 17251472
references.citation: Exp Eye Res. 1997 Jan;64(1):85-96
references.pmid: 9093024
references.citation: J Neurosci. 1983 Oct;3(10):2030-42
references.pmid: 6619922
references.citation: Neurobiol Aging. 2005 Jun;26(6):965-72
references.pmid: 15718056
references.citation: Brain Res. 1986 Oct 8;384(2):205-17
references.pmid: 2946358
references.citation: Neuropsychopharmacology. 2008 Jan;33(1):18-41
references.pmid: 17728696
references.citation: Am J Ophthalmol. 1989 Aug 15;108(2):147-52
references.pmid: 2787961
references.citation: Trends Neurosci. 1995 Feb;18(2):54-6
references.pmid: 7537406
references.citation: J Glaucoma. 2005 Aug;14(4):315-7
references.pmid: 15990616
references.citation: Invest Ophthalmol Vis Sci. 2006 Feb;47(2):626-33
references.pmid: 16431960
references.citation: Brain Behav Evol. 1985;26(1):10-48
references.pmid: 3902145
references.citation: Prog Retin Eye Res. 2007 Jan;26(1):38-56
references.pmid: 17126063
references.citation: Science. 1971 Feb 26;171(3973):804-7
references.pmid: 5549304
references.citation: Neurosci Lett. 1997 Jan 17;221(2-3):153-6
references.pmid: 9121687
references.citation: Exp Brain Res. 1998 Jun;120(3):335-44
references.pmid: 9628420
references.citation: Eur J Neurosci. 1994 Jan 1;6(1):161-9
references.pmid: 7907520
references.citation: Vis Neurosci. 2006 Jan-Feb;23(1):137-42
references.pmid: 16597357
references.citation: Eur J Neurosci. 1998 Jan;10(1):350-7
references.pmid: 9753143
references.citation: Neurobiol Dis. 2000 Oct;7(5):515-9
references.pmid: 11042066
references.citation: Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13444-9
references.pmid: 17684098
references.citation: J Neurophysiol. 1999 Oct;82(4):2020-3
references.pmid: 10515994
references.citation: Am J Ophthalmol. 2006 Feb;141(2):394-6
references.pmid: 16458708
references.citation: Eur J Neurosci. 2000 Sep;12(9):3155-62
references.pmid: 10998099
references.citation: J Glaucoma. 2007 Aug;16(5):483-505
references.pmid: 17700292
references.citation: Exp Eye Res. 2007 Jan;84(1):176-84
references.pmid: 17094963
references.citation: Bull World Health Organ. 2004 Nov;82(11):844-51
references.pmid: 15640920
references.citation: Exp Brain Res. 2001 Oct;140(4):486-94
references.pmid: 11685402
references.citation: J Neurosci. 2001 Jan 15;21(2):691-9
references.pmid: 11160448
references.citation: Eur J Neurosci. 2001 Oct;14(8):1185-93
references.pmid: 11703447
references.citation: Eur J Neurosci. 2004 Sep;20(5):1331-40
references.pmid: 15341604
references.citation: Neuroscience. 1987 Feb;20(2):365-83
references.pmid: 3035421
references.citation: Vis Neurosci. 1997 Mar-Apr;14(2):387-93
references.pmid: 9147489
references.citation: Trends Neurosci. 1993 Dec;16(12):521-7
references.pmid: 7509523
references.citation: Am J Ophthalmol. 1996 Sep;122(3):404-15
references.pmid: 8794713
references.citation: Br J Ophthalmol. 2005 Sep;89(9):1210-6
references.pmid: 16113384
references.citation: Trends Pharmacol Sci. 2000 Jan;21(1):16-9
references.pmid: 10637650
references.citation: J Comp Neurol. 1996 Aug 05;371(4):633-48
references.pmid: 8841915
references.citation: J Comp Neurol. 1988 Oct 8;276(2):169-87
references.pmid: 3220979
references.citation: Invest Ophthalmol Vis Sci. 2005 Jan;46(1):175-82
references.pmid: 15623771
references.citation: Eur J Pharmacol. 1988 Dec 13;158(3):217-24
references.pmid: 2855312
references.citation: Brain Res. 1991 Feb 1;540(1-2):243-54
references.pmid: 1675915
references.citation: Neurosci Lett. 1991 Aug 19;129(2):161-4
references.pmid: 1684025
references.citation: Eur J Neurosci. 2005 Oct;22(7):1643-54
references.pmid: 16197505